Article Details

Adaptin Bio Announces FDA Clearance of IND Application for APTN-101 in Glioblastoma

Retrieved on: 2024-09-05 04:24:36

Tags for this article:

Click the tags to see associated articles and topics

Adaptin Bio Announces FDA Clearance of IND Application for APTN-101 in Glioblastoma. View article details on hiswai:

Excerpt

“Our proprietary BRiTE technology harnesses the immune system's remarkable ability to target and deliver therapeutics to specific tissues, including ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up